Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Avacta Sponsors 5th Annual Protein Formulation Development and Drug Delivery Forum

Published: Tuesday, June 03, 2014
Last Updated: Tuesday, June 03, 2014
Bookmark and Share
Company will showcase the capabilities of the Optim 2 instrument at the event.

Avacta Analytical has announced its sponsorship of this year’s Protein Formulation Development and Drug Delivery Forum in Barcelona, Spain.

Now in its fifth year, this exciting event runs from the 9th to the 11th of June, and will bring together research scientists from across the pharmaceutical and biotechnology sectors to explore current issues in protein formulation.

Protein formulation has become a highly important area of research for the pharmaceutical industry, and there is now increasing pressure to optimize drug formulations earlier in the development process to help avoid downstream failures and accelerate time-to-market.

This event will look at the latest innovations in protein formulation and drug delivery, highlighting recent research and technological advances - as well as updates to the regulatory framework - which can help to streamline and simplify formulation development activities.

Avacta will be showcasing the low volume protein characterization capabilities of the Optim 2 instrument at the event, giving delegates the opportunity to discuss how the system could help benefit their research with the Company’s technical experts.

Avacta’s Dr Geoff Platt will also be hosting a seminar entitled: ‘Strategy for stability assessment of antibodies: high throughput screening as a predictive tool for accelerating development’, providing practical examples of how novel technologies such as the Optim system can reduce the time and cost of therapeutic protein preformulation studies, protein stability testing and formulation development.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Fly Study into Therapies for HVP-Induced Cancer
Fruit flies may help scientists understand the mechanism by which HPV can cause cancer as well as identify potential drug treatments.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
'Missing Evolutionary Link' of Natural Drug Source Found
Scripps Florida study finds 'missing evolutionary link' of a widely used natural drug source
Grad Student's Finding Enables Rapid Compound Screening
Grad student makes technical leap that could enable rapid screening of anti-cancer compounds.
Uncovering Constructor Proteins
Scientists have discovered a new bacterial cell wall builder that could be a target for antibiotic development.
Cholesterol Linked to Aggressive Cancers
Research suggests fats, such as cholesterol, can increase aggressive cancer progression.
Biomarker Breakthrough Could Improve Parkinson’s Treatment
A new method of tracking Parkinson's progression could aid evaluation of new and experimental treatments to slow or stop the disease.
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
How Parkinson’s Disease Alters Brain Activity Over Time
The NIH study provides a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!